vs
Nextpower Inc.（NXT）与Revvity（RVTY）财务数据对比。点击上方公司名可切换其他公司
Nextpower Inc.的季度营收约是Revvity的1.2倍（$909.4M vs $772.1M），Nextpower Inc.净利率更高（14.4% vs 12.7%，领先1.7%），Nextpower Inc.同比增速更快（33.9% vs 5.9%），Revvity自由现金流更多（$161.8M vs $118.5M），过去两年Nextpower Inc.的营收复合增速更高（11.1% vs 9.0%）
Nextpower Inc（股票代码：NXT）是一家总部位于美国加利福尼亚州弗里蒙特市的全球化能源科技企业，专注于为全球市场提供先进的能源技术解决方案及相关服务，业务覆盖全球多个国家和地区，在能源技术领域拥有较强的技术积累与市场竞争力。
Revvity是一家美国生命科学与诊断领域企业，主要服务制药、生物技术行业客户，重点围绕细胞治疗、基因治疗等前沿技术领域提供相关产品与解决方案，其前身为业务布局多元的老牌企业珀金埃尔默。
NXT vs RVTY — 直观对比
营收规模更大
NXT
是对方的1.2倍
$772.1M
营收增速更快
NXT
高出28.0%
5.9%
净利率更高
NXT
高出1.7%
12.7%
自由现金流更多
RVTY
多$43.2M
$118.5M
两年增速更快
NXT
近两年复合增速
9.0%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $909.4M | $772.1M |
| 净利润 | $131.2M | $98.4M |
| 毛利率 | 31.7% | — |
| 营业利润率 | 19.4% | 14.5% |
| 净利率 | 14.4% | 12.7% |
| 营收同比 | 33.9% | 5.9% |
| 净利润同比 | 13.8% | 3.9% |
| 每股收益（稀释后） | $0.85 | $0.86 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NXTRVTY
| Q4 25 | $909.4M | $772.1M | ||
| Q3 25 | $905.3M | $698.9M | ||
| Q2 25 | $864.3M | $720.3M | ||
| Q1 25 | $924.3M | $664.8M | ||
| Q4 24 | $679.4M | $729.4M | ||
| Q3 24 | $635.6M | $684.0M | ||
| Q2 24 | $719.9M | $691.7M | ||
| Q1 24 | $736.5M | $649.9M |
净利润NXTRVTY
| Q4 25 | $131.2M | $98.4M | ||
| Q3 25 | $146.9M | $46.7M | ||
| Q2 25 | $157.2M | $53.9M | ||
| Q1 25 | $156.8M | $42.2M | ||
| Q4 24 | $115.3M | $94.6M | ||
| Q3 24 | $115.4M | $94.4M | ||
| Q2 24 | $121.7M | $55.4M | ||
| Q1 24 | $205.2M | $26.0M |
毛利率NXTRVTY
| Q4 25 | 31.7% | — | ||
| Q3 25 | 32.4% | 53.6% | ||
| Q2 25 | 32.6% | 54.5% | ||
| Q1 25 | 33.1% | 56.5% | ||
| Q4 24 | 35.5% | — | ||
| Q3 24 | 35.4% | 56.3% | ||
| Q2 24 | 33.0% | 55.7% | ||
| Q1 24 | 46.2% | 54.6% |
营业利润率NXTRVTY
| Q4 25 | 19.4% | 14.5% | ||
| Q3 25 | 20.0% | 11.7% | ||
| Q2 25 | 21.5% | 12.6% | ||
| Q1 25 | 21.1% | 10.9% | ||
| Q4 24 | 22.1% | 16.3% | ||
| Q3 24 | 21.0% | 14.3% | ||
| Q2 24 | 22.2% | 12.4% | ||
| Q1 24 | 36.8% | 6.8% |
净利率NXTRVTY
| Q4 25 | 14.4% | 12.7% | ||
| Q3 25 | 16.2% | 6.7% | ||
| Q2 25 | 18.2% | 7.5% | ||
| Q1 25 | 17.0% | 6.4% | ||
| Q4 24 | 17.0% | 13.0% | ||
| Q3 24 | 18.2% | 13.8% | ||
| Q2 24 | 16.9% | 8.0% | ||
| Q1 24 | 27.9% | 4.0% |
每股收益（稀释后）NXTRVTY
| Q4 25 | $0.85 | $0.86 | ||
| Q3 25 | $0.97 | $0.40 | ||
| Q2 25 | $1.04 | $0.46 | ||
| Q1 25 | $1.05 | $0.35 | ||
| Q4 24 | $0.79 | $0.77 | ||
| Q3 24 | $0.79 | $0.77 | ||
| Q2 24 | $0.84 | $0.45 | ||
| Q1 24 | $1.52 | $0.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $952.6M | $919.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $2.2B | $7.3B |
| 总资产 | $3.8B | $12.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资NXTRVTY
| Q4 25 | $952.6M | $919.9M | ||
| Q3 25 | $845.3M | $931.4M | ||
| Q2 25 | $743.4M | $991.8M | ||
| Q1 25 | $766.1M | $1.1B | ||
| Q4 24 | $693.5M | $1.2B | ||
| Q3 24 | $561.9M | $1.2B | ||
| Q2 24 | $471.9M | $2.0B | ||
| Q1 24 | $474.1M | $1.7B |
股东权益NXTRVTY
| Q4 25 | $2.2B | $7.3B | ||
| Q3 25 | $2.0B | $7.4B | ||
| Q2 25 | $1.8B | $7.6B | ||
| Q1 25 | $1.6B | $7.6B | ||
| Q4 24 | $1.4B | $7.7B | ||
| Q3 24 | $1.3B | $7.9B | ||
| Q2 24 | $1.1B | $7.9B | ||
| Q1 24 | $961.0M | $7.8B |
总资产NXTRVTY
| Q4 25 | $3.8B | $12.2B | ||
| Q3 25 | $3.7B | $12.1B | ||
| Q2 25 | $3.4B | $12.4B | ||
| Q1 25 | $3.2B | $12.4B | ||
| Q4 24 | $3.0B | $12.4B | ||
| Q3 24 | $2.8B | $12.8B | ||
| Q2 24 | $2.6B | $13.4B | ||
| Q1 24 | $2.5B | $13.4B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $123.3M | $182.0M |
| 自由现金流经营现金流 - 资本支出 | $118.5M | $161.8M |
| 自由现金流率自由现金流/营收 | 13.0% | 21.0% |
| 资本支出强度资本支出/营收 | 0.5% | 2.6% |
| 现金转化率经营现金流/净利润 | 0.94× | 1.85× |
| 过去12个月自由现金流最近4个季度 | $587.3M | $509.4M |
8季度趋势，按日历期对齐
经营现金流NXTRVTY
| Q4 25 | $123.3M | $182.0M | ||
| Q3 25 | $186.9M | $138.5M | ||
| Q2 25 | $81.3M | $134.3M | ||
| Q1 25 | $237.3M | $128.2M | ||
| Q4 24 | $143.8M | $174.2M | ||
| Q3 24 | $153.8M | $147.9M | ||
| Q2 24 | $120.8M | $158.6M | ||
| Q1 24 | $111.5M | $147.6M |
自由现金流NXTRVTY
| Q4 25 | $118.5M | $161.8M | ||
| Q3 25 | $171.4M | $120.0M | ||
| Q2 25 | $70.1M | $115.5M | ||
| Q1 25 | $227.2M | $112.2M | ||
| Q4 24 | $134.9M | $149.8M | ||
| Q3 24 | $141.8M | $125.6M | ||
| Q2 24 | $118.0M | $136.6M | ||
| Q1 24 | $109.2M | $129.7M |
自由现金流率NXTRVTY
| Q4 25 | 13.0% | 21.0% | ||
| Q3 25 | 18.9% | 17.2% | ||
| Q2 25 | 8.1% | 16.0% | ||
| Q1 25 | 24.6% | 16.9% | ||
| Q4 24 | 19.9% | 20.5% | ||
| Q3 24 | 22.3% | 18.4% | ||
| Q2 24 | 16.4% | 19.7% | ||
| Q1 24 | 14.8% | 20.0% |
资本支出强度NXTRVTY
| Q4 25 | 0.5% | 2.6% | ||
| Q3 25 | 1.7% | 2.6% | ||
| Q2 25 | 1.3% | 2.6% | ||
| Q1 25 | 1.1% | 2.4% | ||
| Q4 24 | 1.3% | 3.4% | ||
| Q3 24 | 1.9% | 3.3% | ||
| Q2 24 | 0.4% | 3.2% | ||
| Q1 24 | 0.3% | 2.7% |
现金转化率NXTRVTY
| Q4 25 | 0.94× | 1.85× | ||
| Q3 25 | 1.27× | 2.97× | ||
| Q2 25 | 0.52× | 2.49× | ||
| Q1 25 | 1.51× | 3.03× | ||
| Q4 24 | 1.25× | 1.84× | ||
| Q3 24 | 1.33× | 1.57× | ||
| Q2 24 | 0.99× | 2.87× | ||
| Q1 24 | 0.54× | 5.67× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NXT
| Transferred Over Time | $763.9M | 84% |
| Transferred At Point In Time | $145.4M | 16% |
RVTY
| Immunodiagnostics | $240.8M | 31% |
| Life Sciences | $191.4M | 25% |
| Reproductive Health | $149.3M | 19% |
| Segment Operating Income | $132.0M | 17% |
| Software | $62.3M | 8% |
